Caligan Partners, LP

Entreprise	Partager, %
Anika Therapeutics	9.95
Liquidia Corporation	9.33
Evolus, Inc.	6.39
Alimera Sciences, Inc.	5.44
Mineralys Therapeutics, Inc.	3.5
Intercept Pharmaceuticals	3.09
Societal CDMO, Inc.	1.61